Dulac Edward J III 4
4 · Intellia Therapeutics, Inc. · Filed Jul 24, 2024
Insider Transaction Report
Form 4
Dulac Edward J III
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2024-07-22+66,324→ 66,324 total - Award
Stock Option (right to buy)
2024-07-22+96,219→ 96,219 totalExercise: $25.33Exp: 2034-07-21→ Common Stock (96,219 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on July 22, 2024 with respect to shares of Common Stock, with 33% vesting on July 22, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.